What is the order of medications to give for hyperkalemia (elevated potassium levels)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Order of Medications for Hyperkalemia Treatment

For hyperkalemia with ECG changes or potassium ≥6.5 mEq/L, immediately administer intravenous calcium (calcium chloride 10%: 5-10 mL or calcium gluconate 10%: 15-30 mL over 2-5 minutes) to stabilize cardiac membranes, followed simultaneously by insulin with glucose (10 units regular insulin IV with 25g glucose over 15-30 minutes) and nebulized albuterol (10-20 mg over 15 minutes) to shift potassium into cells, then initiate potassium elimination with loop diuretics or hemodialysis depending on renal function. 1, 2, 3

Step-by-Step Treatment Algorithm

Step 1: Cardiac Membrane Stabilization (IMMEDIATE - within 1-3 minutes)

This is your first intervention for any hyperkalemia with ECG changes (peaked T waves, flattened P waves, prolonged PR interval, widened QRS) or potassium ≥6.5 mEq/L. 1, 2

  • Calcium chloride (10%): 5-10 mL (500-1000 mg) IV over 2-5 minutes 1, 2

    • Preferred in critically ill patients as it provides more rapid increase in ionized calcium 1
    • Administer through central line when possible due to tissue necrosis risk with extravasation 1
    • Monitor heart rate during administration; stop if symptomatic bradycardia occurs 1
  • Alternative: Calcium gluconate (10%): 15-30 mL IV over 2-5 minutes 1, 2

    • Safer for peripheral IV access 1
    • Less tissue damage if extravasation occurs 1
  • Onset: 1-3 minutes; Duration: 30-60 minutes 1, 2

  • Critical caveat: Calcium does NOT lower potassium—it only protects the heart temporarily 1, 2

  • Repeat dose: If no ECG improvement within 5-10 minutes, give another dose 2

Step 2: Shift Potassium into Cells (START SIMULTANEOUSLY - onset 15-30 minutes)

Begin these therapies immediately after or concurrent with calcium administration. Do not wait for calcium to finish. 1, 2

Primary Shifting Agents (use BOTH together):

  • Insulin + Glucose: 10 units regular insulin IV with 25g glucose (50 mL D50W) over 15-30 minutes 1, 2, 3

    • Onset: 15-30 minutes; Duration: 4-6 hours 1, 2
    • Monitor glucose closely to prevent hypoglycemia 1
    • Can repeat every 4-6 hours if hyperkalemia persists 1
    • Recheck potassium within 1-2 hours after administration 2
  • Nebulized albuterol: 10-20 mg over 15 minutes 1, 2, 3

    • Onset: 15-30 minutes; Duration: 2-4 hours 1, 2
    • Augments insulin effect when used together 1, 4
    • Can lower potassium by 0.5-1.0 mEq/L 1

Adjunctive Shifting Agent (use ONLY if metabolic acidosis present):

  • Sodium bicarbonate: 50 mEq IV over 5 minutes 1, 2
    • ONLY use if concurrent metabolic acidosis (pH <7.35, bicarbonate <22 mEq/L) 1, 2
    • Onset: 30-60 minutes 2
    • Do NOT use routinely without acidosis—it is ineffective 2, 5

Critical warning: All shifting agents are temporary (lasting 1-6 hours) and rebound hyperkalemia can occur after 2 hours. 1 You MUST proceed to Step 3 for definitive potassium removal. 1

Step 3: Eliminate Potassium from Body (START WITHIN 1-2 HOURS - definitive treatment)

Choose based on renal function and severity. 1, 2

If adequate renal function (eGFR >30 mL/min):

  • Loop diuretics: Furosemide 40-80 mg IV 1, 2
    • Increases renal potassium excretion 1, 2
    • Only effective with adequate kidney function 1, 2
    • Titrate to maintain euvolemia 2

For subacute management or inadequate renal response:

  • Newer potassium binders (PREFERRED): 1, 2

    • Sodium zirconium cyclosilicate (SZC/Lokelma): 10g three times daily for 48 hours, then 5-15g once daily 2
      • Onset: ~1 hour 2
      • Safer than older resins 1
    • Patiromer (Veltassa): 8.4g once daily, titrate up to 25.2g daily 2
      • Onset: ~7 hours 2
  • Older resin (use only if newer agents unavailable):

    • Sodium polystyrene sulfonate (Kayexalate): 15-50g orally or rectally with sorbitol 1
      • Delayed onset, risk of bowel necrosis 2
      • NOT effective for acute management 5

If severe hyperkalemia (≥6.5 mEq/L) with renal failure or refractory to medical treatment:

  • Hemodialysis 1, 2, 3
    • Most effective and reliable method for potassium removal 1, 2, 5
    • Definitive treatment for end-stage renal disease patients 1, 5
    • Use for oliguria, acute kidney injury, or failure of medical management 2

Severity-Based Treatment Protocols

Mild Hyperkalemia (5.0-5.9 mEq/L, no ECG changes):

  • Review and stop contributing medications (ACE inhibitors, ARBs, NSAIDs, potassium supplements) 1, 2
  • Initiate potassium binder if on RAAS inhibitors 1, 2
  • Monitor potassium within 7-10 days 2

Moderate Hyperkalemia (6.0-6.4 mEq/L, no ECG changes):

  • Insulin + glucose 2
  • Nebulized albuterol 2
  • Potassium binder 2
  • Consider calcium if any ECG changes develop 2

Severe Hyperkalemia (≥6.5 mEq/L OR any ECG changes):

  • ALL THREE STEPS simultaneously: 1, 2, 3
    1. Calcium (immediate)
    2. Insulin + glucose + albuterol (within minutes)
    3. Diuretics or dialysis (within 1-2 hours)

Critical Monitoring Parameters

  • Recheck potassium: 2

    • Within 1-2 hours after insulin/glucose or albuterol 2
    • Every 2-4 hours during acute treatment phase 1
    • Within 5-10 minutes if no ECG improvement after calcium 2
  • Continuous cardiac monitoring required for severe hyperkalemia 1, 2, 3

Common Pitfalls to Avoid

  • Never rely on calcium alone—it does NOT lower potassium, only protects the heart temporarily 1, 2
  • Never use bicarbonate without metabolic acidosis—it is ineffective and delays appropriate treatment 2, 5
  • Never forget glucose with insulin—hypoglycemia can be life-threatening 1
  • Never assume shifting agents are definitive—rebound hyperkalemia occurs within 2-6 hours without potassium elimination 1
  • Never use sodium polystyrene sulfonate for acute management—it has delayed onset and serious GI risks 2, 5
  • Always check magnesium—hypomagnesemia can worsen cardiac effects 2

References

Guideline

Immediate Treatment for Hyperkalemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hyperkalemia Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment and pathogenesis of acute hyperkalemia.

Journal of community hospital internal medicine perspectives, 2011

Research

Management of hyperkalaemia.

The journal of the Royal College of Physicians of Edinburgh, 2013

Research

Management of hyperkalemia in dialysis patients.

Seminars in dialysis, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.